FDA must rewrite rules to formally allow non-animal drug testing methods
Passed one chamberH.R. 2821Latest action
Sponsor: Earl L. "Buddy" Carter · Representative · GA
AIDecoded by AI · checked against the recordRead the official text
Official title: FDA Modernization Act 3.0
119th Congress
Topics: Health care
Introduced:
Read the official bill on Congress.govIn plain words
The plain-language version comes first. The official text is always the reference.
HR 2821 gives the FDA one year to update regulations so they officially reflect a 2022 law allowing non-animal drug testing methods.
50-second read · 4 questions answered below
What does this do?
HR 2821 requires the FDA to rewrite specific regulations within one year, replacing outdated "animal" testing language with the broader term "nonclinical testing." This aligns the FDA's actual rules with a 2022 law that already allows drug companies to use alternatives like lab-grown tissue models, organ-on-a-chip technology, or computer simulations. The bill also lets the FDA skip some standard public-comment procedures so the update can take effect immediately, and fixes a duplicate section label from prior law.
Who does it affect?
Pharmaceutical and biotech companies developing new drugs, plus researchers working on alternative testing methods, are directly affected. Patients could be indirectly affected through changes in how drug development timelines and testing options play out.
Why does it matter?
The mismatch between the 2022 law and outdated FDA regulations has created confusion over whether non-animal testing methods are truly permitted. Updating the rules removes that legal ambiguity and may also reduce the number of animals used in laboratory research.
AI-drafted summary. Check it against the official text before you act on it.
Read the official bill on Congress.govMake the call
Where does it stand?
- IntroducedApr 10, 2025
- House committee
- House vote
- SenateYou are here · Jul 21, 2026
- The president's desk
Right now: it passed the House, and the official record shows nothing new since. If the Senate changes it, it goes back to the House before reaching the president.
Latest action: — Received in the Senate.